Teva Pharmaceutical Industries (TEVA) Competitors

Takeda Pharmaceutical (NYSE:TAK) and Teva Pharmaceutical Industries (NYSE:TEVA) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, profitability, community ranking, valuation, analyst recommendations, institutional ownership, earnings and risk.

Do insiders and institutionals hold more shares of TAK or TEVA?

9.2% of Takeda Pharmaceutical shares are owned by institutional investors. Comparatively, 54.0% of Teva Pharmaceutical Industries shares are owned by institutional investors. 0.0% of Takeda Pharmaceutical shares are owned by insiders. Comparatively, 0.6% of Teva Pharmaceutical Industries shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Does the media refer more to TAK or TEVA?

In the previous week, Teva Pharmaceutical Industries had 22 more articles in the media than Takeda Pharmaceutical. MarketBeat recorded 27 mentions for Teva Pharmaceutical Industries and 5 mentions for Takeda Pharmaceutical. Takeda Pharmaceutical's average media sentiment score of 0.74 beat Teva Pharmaceutical Industries' score of 0.70 indicating that Takeda Pharmaceutical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Takeda Pharmaceutical	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Teva Pharmaceutical Industries	13 Very Positive mention(s)	1 Positive mention(s)	13 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is TAK or TEVA a better dividend stock?

Takeda Pharmaceutical pays an annual dividend of $0.53 per share and has a dividend yield of 3.5%. Teva Pharmaceutical Industries pays an annual dividend of $1.0110 per share and has a dividend yield of 6.2%. Takeda Pharmaceutical pays out 132.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Teva Pharmaceutical Industries pays out -69.7% of its earnings in the form of a dividend. Teva Pharmaceutical Industries is clearly the better dividend stock, given its higher yield and lower payout ratio.

Is TAK or TEVA more profitable?

Takeda Pharmaceutical has a net margin of 4.53% compared to Teva Pharmaceutical Industries' net margin of -9.91%. Teva Pharmaceutical Industries' return on equity of 42.46% beat Takeda Pharmaceutical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Takeda Pharmaceutical	4.53%	9.39%	4.53%
Teva Pharmaceutical Industries	-9.91%	42.46%	6.65%

Which has preferable valuation and earnings, TAK or TEVA?

Takeda Pharmaceutical has higher revenue and earnings than Teva Pharmaceutical Industries. Teva Pharmaceutical Industries is trading at a lower price-to-earnings ratio than Takeda Pharmaceutical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Takeda Pharmaceutical	$4.58T	0.01	$994.06M	$0.40	37.54
Teva Pharmaceutical Industries	$16.54B	1.11	-$1.64B	-$1.45	-11.16

Which has more risk and volatility, TAK or TEVA?

Takeda Pharmaceutical has a beta of 0.46, suggesting that its share price is 54% less volatile than the S&P 500. Comparatively, Teva Pharmaceutical Industries has a beta of 0.82, suggesting that its share price is 18% less volatile than the S&P 500.

Does the MarketBeat Community prefer TAK or TEVA?

Teva Pharmaceutical Industries received 1233 more outperform votes than Takeda Pharmaceutical when rated by MarketBeat users. Likewise, 67.87% of users gave Teva Pharmaceutical Industries an outperform vote while only 56.82% of users gave Takeda Pharmaceutical an outperform vote.

Company	Underperform	Outperform
Takeda Pharmaceutical	Outperform Votes 100 56.82%	Underperform Votes 76 43.18%
Teva Pharmaceutical Industries	Outperform Votes 1333 67.87%	Underperform Votes 631 32.13%

Do analysts recommend TAK or TEVA?

Teva Pharmaceutical Industries has a consensus target price of $23.43, suggesting a potential upside of 44.82%. Given Teva Pharmaceutical Industries' stronger consensus rating and higher possible upside, analysts plainly believe Teva Pharmaceutical Industries is more favorable than Takeda Pharmaceutical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Takeda Pharmaceutical	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Teva Pharmaceutical Industries	0 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.86

Summary

Teva Pharmaceutical Industries beats Takeda Pharmaceutical on 14 of the 20 factors compared between the two stocks.